Essential Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.5K Sell
41
-1
-2% -$410 0.01% 965
2026
Q2
$16.4K Sell
42
-235
-85% -$99.3K 0.01% 986
2026
Q1
$131K Sell
277
-87
-24% -$43.8K 0.04% 359
2025
Q4
$170K Buy
364
+108
+42% +$50.1K 0.05% 347
2025
Q3
$109K Buy
256
+87
+51% +$33.7K 0.04% 416
2025
Q2
$64.7K Buy
+169
New +$60.9K 0.03% 421

Other funds holding HCA

Essential Partners's HCA Position: Q3 2026 in Review

Essential Partners reduced its HCA Healthcare (HCA) stake by 2.4% in Q3 2026, selling an estimated $410 and leaving 41 shares worth $17.5K. The position accounts for 0.01% of the portfolio, ranked #965.

Essential Partners first reported a position in HCA in Q2 2025 and has held it in 6 quarters since. The position peaked at $170K in Q4 2025. 144 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Essential Partners held 41 shares of HCA Healthcare worth $17.5K as of Q3 2026.
  • Essential Partners sold 1 HCA Healthcare share in Q3 2026, an estimated $410.
  • HCA Healthcare made up 0.01% of Essential Partners's portfolio in Q3 2026, its #965 holding.
  • Essential Partners first reported a position in HCA Healthcare in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's HCA Healthcare position peaked at $170K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.